Welcome to ESGCT

The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe.

XVIIIth Annual Congress of the European Society of Gene & Cell Therapy

Congress registration
Abstract submission
Congress programme
Clinigene Industry Satellite

22 - 25 October 2010
Milano

Image of Milan, home to the 18th ESGCT Annual Congress

23 July 2010

3rd ATTACK Cellular Therapy of Cancer...

Takes place between the 24th and 27th September 2010 in Montpellier

21 July 2010

CliniGene Competitive Call for Additional...

CliniGene seeks additional partners to enter its Joint Programme Activity

2 June 2010

ISCT Abstract deadline has been extended...

Notification: ISCT Europe 2nd Regional Meeting in Belgirate Italy (11-14 September 2010) Abstract deadline has been extended till...

24 May 2010

ISCT Europe 2nd regional meeting in...

11-14 September 2010

24 May 2010

ISCT Europe 2nd regional meeting in...

11-14 September 2010

10 May 2010

Symposium and EMBO practical course "Viral...

You are kindly invited to participate in the Symposium and the EMBO practical course (full event) or in the Symposium only (26-29 Aug)

Human Gene Therapy - Official Journal of the European Society of Gene & Cell Therapy

A Letter from the President

“The primary objectives of ESGCT are thus to promote basic and clinical research in gene therapy, to facilitate education and the exchange of information and technologies related to gene therapy and to serve as a professional adviser to the community and to the regulatory bodies in Europe. Together we can make a real difference in the hope of ultimately curing diseases by gene and cell therapy and alleviate human suffering...”

Prof. Thierry VandenDriessche
President ESGCT

Signature of the ESGCT president